Annual SGA
$62.77 M
-$68.09 M-52.03%
December 31, 2023
Summary
- As of February 7, 2025, BHVN annual SGA is $62.77 million, with the most recent change of -$68.09 million (-52.03%) on December 31, 2023.
- During the last 3 years, BHVN annual SGA has risen by +$46.72 million (+291.19%).
- BHVN annual SGA is now -53.31% below its all-time high of $134.45 million, reached on December 31, 2019.
Performance
BHVN SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$20.56 M
+$1.61 M+8.48%
September 30, 2024
Summary
- As of February 7, 2025, BHVN quarterly SGA is $20.56 million, with the most recent change of +$1.61 million (+8.48%) on September 30, 2024.
- Over the past year, BHVN quarterly SGA has increased by +$1.66 million (+8.80%).
- BHVN quarterly SGA is now -83.53% below its all-time high of $124.80 million, reached on June 1, 2020.
Performance
BHVN Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$3.34 B
-$804.34 M-31.78%
September 30, 2024
Summary
- As of February 7, 2025, BHVN TTM SGA is -$3.34 billion, with the most recent change of -$804.34 million (-31.78%) on September 30, 2024.
- Over the past year, BHVN TTM SGA has dropped by -$3.40 billion (-5413.89%).
- BHVN TTM SGA is now -4320.49% below its all-time high of -$75.46 million.
Performance
BHVN TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
BHVN Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -52.0% | +8.8% | -5413.9% |
| 3 y3 years | +291.2% | -73.1% | -2648.9% |
| 5 y5 years | +81.4% | -73.1% | -2648.9% |
BHVN Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -52.0% | +67.8% | -73.1% | +126.8% | -3560.4% | at low |
| 5 y | 5-year | -53.3% | +291.2% | -83.5% | +141.3% | -3560.4% | +49.4% |
| alltime | all time | -53.3% | +2837.3% | -83.5% | +3254.2% | -4320.5% | +49.4% |
Biohaven Pharmaceutical Holding Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $20.56 M(+8.5%) | $85.68 M(+6.9%) |
| Jun 2024 | - | $18.95 M(-30.5%) | $80.15 M(+5.9%) |
| Mar 2024 | - | $27.27 M(+44.3%) | $75.72 M(+20.6%) |
| Dec 2023 | $62.77 M(-52.0%) | $18.90 M(+25.7%) | $62.77 M(-47.8%) |
| Sep 2023 | - | $15.03 M(+3.5%) | $120.24 M(+0.2%) |
| Jun 2023 | - | $14.52 M(+1.4%) | $120.00 M(-4.4%) |
| Mar 2023 | - | $14.32 M(-81.2%) | $125.50 M(-4.1%) |
| Dec 2022 | $130.86 M(+249.8%) | $76.37 M(+416.3%) | $130.86 M(+105.9%) |
| Sep 2022 | - | $14.79 M(-26.1%) | $63.56 M(+11.0%) |
| Jun 2022 | - | $20.02 M(+1.8%) | $57.28 M(+53.7%) |
| Mar 2022 | - | $19.68 M(+117.1%) | $37.26 M(+111.9%) |
| Dec 2021 | $37.41 M(+133.2%) | - | - |
| Dec 2021 | - | $9.06 M(+6.4%) | $17.58 M(-86.6%) |
| Sep 2021 | - | $8.52 M(-93.0%) | $130.91 M(-71.7%) |
| Dec 2020 | $16.05 M(-88.1%) | - | - |
| Dec 2020 | - | $122.39 M(+2.4%) | $462.32 M(+13.1%) |
| Sep 2020 | - | $119.53 M(-4.2%) | $408.92 M(+28.5%) |
| Jun 2020 | - | $124.80 M(+30.5%) | $318.16 M(+46.9%) |
| Mar 2020 | - | $95.60 M(+38.6%) | $216.59 M(+61.1%) |
| Dec 2019 | $134.45 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | - | $68.98 M(+139.7%) | $134.45 M(+77.9%) |
| Sep 2019 | - | $28.78 M(+23.9%) | $75.58 M(+39.0%) |
| Jun 2019 | - | $23.23 M(+72.6%) | $54.37 M(+35.2%) |
| Mar 2019 | - | $13.46 M(+33.1%) | $40.20 M(+16.2%) |
| Dec 2018 | $34.60 M(+90.7%) | - | - |
| Dec 2018 | - | $10.11 M(+33.5%) | $34.60 M(+14.9%) |
| Sep 2018 | - | $7.57 M(-16.4%) | $30.11 M(+11.1%) |
| Jun 2018 | - | $9.06 M(+15.4%) | $27.11 M(+21.9%) |
| Mar 2018 | - | $7.86 M(+40.0%) | $22.24 M(+22.6%) |
| Dec 2017 | $18.14 M(+255.1%) | - | - |
| Dec 2017 | - | $5.61 M(+22.8%) | $18.14 M(+21.1%) |
| Sep 2017 | - | $4.57 M(+8.9%) | $14.98 M(+32.2%) |
| Jun 2017 | - | $4.20 M(+11.8%) | $11.33 M(+37.3%) |
| Mar 2017 | - | $3.76 M(+53.2%) | $8.25 M(+61.5%) |
| Dec 2016 | $5.11 M(+139.1%) | - | - |
| Dec 2016 | - | $2.45 M(+166.5%) | $5.11 M(+92.3%) |
| Sep 2016 | - | $920.00 K(-18.1%) | $2.66 M(+53.0%) |
| Jun 2016 | - | $1.12 M(+83.4%) | $1.74 M(+183.4%) |
| Mar 2016 | - | $613.00 K | $613.00 K |
| Dec 2015 | $2.14 M | - | - |
FAQ
- What is Biohaven Pharmaceutical Holding annual SGA?
- What is the all time high annual SGA for Biohaven Pharmaceutical Holding?
- What is Biohaven Pharmaceutical Holding annual SGA year-on-year change?
- What is Biohaven Pharmaceutical Holding quarterly SGA?
- What is the all time high quarterly SGA for Biohaven Pharmaceutical Holding?
- What is Biohaven Pharmaceutical Holding quarterly SGA year-on-year change?
- What is Biohaven Pharmaceutical Holding TTM SGA?
- What is the all time high TTM SGA for Biohaven Pharmaceutical Holding?
- What is Biohaven Pharmaceutical Holding TTM SGA year-on-year change?
What is Biohaven Pharmaceutical Holding annual SGA?
The current annual SGA of BHVN is $62.77 M
What is the all time high annual SGA for Biohaven Pharmaceutical Holding?
Biohaven Pharmaceutical Holding all-time high annual SGA is $134.45 M
What is Biohaven Pharmaceutical Holding annual SGA year-on-year change?
Over the past year, BHVN annual SGA has changed by -$68.09 M (-52.03%)
What is Biohaven Pharmaceutical Holding quarterly SGA?
The current quarterly SGA of BHVN is $20.56 M
What is the all time high quarterly SGA for Biohaven Pharmaceutical Holding?
Biohaven Pharmaceutical Holding all-time high quarterly SGA is $124.80 M
What is Biohaven Pharmaceutical Holding quarterly SGA year-on-year change?
Over the past year, BHVN quarterly SGA has changed by +$1.66 M (+8.80%)
What is Biohaven Pharmaceutical Holding TTM SGA?
The current TTM SGA of BHVN is -$3.34 B
What is the all time high TTM SGA for Biohaven Pharmaceutical Holding?
Biohaven Pharmaceutical Holding all-time high TTM SGA is -$75.46 M
What is Biohaven Pharmaceutical Holding TTM SGA year-on-year change?
Over the past year, BHVN TTM SGA has changed by -$3.40 B (-5413.89%)